| __timestamp | Sarepta Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 7751000 |
| Thursday, January 1, 2015 | 75043000 | 10251000 |
| Friday, January 1, 2016 | 83749000 | 9575000 |
| Sunday, January 1, 2017 | 122682000 | 10912000 |
| Monday, January 1, 2018 | 207761000 | 11049000 |
| Tuesday, January 1, 2019 | 284812000 | 11646000 |
| Wednesday, January 1, 2020 | 317875000 | 13265000 |
| Friday, January 1, 2021 | 282660000 | 25805000 |
| Saturday, January 1, 2022 | 451421000 | 35182000 |
| Sunday, January 1, 2023 | 481871000 | 94999000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Viridian Therapeutics, Inc. over the past decade. From 2014 to 2023, Sarepta's SG&A expenses surged by over 870%, reflecting its aggressive growth strategy. In contrast, Viridian's expenses increased by approximately 1,125%, albeit from a much smaller base, indicating its rapid expansion phase.
This financial journey underscores the strategic priorities of these companies as they navigate the biotech landscape.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and Viridian Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Viridian Therapeutics, Inc.: SG&A Expense Trends
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and CRISPR Therapeutics AG
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Ultragenyx Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Vericel Corporation and Viridian Therapeutics, Inc.
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ligand Pharmaceuticals Incorporated and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared